Literature DB >> 16619813

[Visual evoked potentials in children with high blood lead level].

Dorota Pojda-Wilczek1, Ewa Herba, Barbara Schneiberg.   

Abstract

PURPOSE: The aim of this study is to find the relationship between lead level in blood (Pb-B) and visual evoked potentials (VEP) in children, environmentally exposed to lead.
MATERIAL AND METHODS: 32 children (64 eyes) with no clinical signs of lead poisoning were examined. Corrected visual acuity was 5/5 in all eyes. Age of the children was 2-15.5 years (mean 8), Pb-B ranged from 150 to 486 (mean 262) microg/l. For pattern VEP LKC equipment, UTAS E-2000 program and stimulations of 13', 26', 52', 105' were used. P100 amplitude and latency were calculated.
RESULTS: P100 latency was significantly delayed in children at the age of seven, with Pb-B above 150 microg/l. The latencies were more delayed in children with higher than in lower Pb-B, but the relation was not linear. P100 amplitudes did not differ significantly from the control group. In some children VEP had abnormal morphology, double P100 peak or P100 without sharp, but extended peak.
CONCLUSION: Delayed P100 PVEP latency occurred in children with blood lead level higher than 150 microg/l, after at least 7 years of environmental exposure. Changes in VEP are similar to those which are caused by demyelinization and are found in multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16619813

Source DB:  PubMed          Journal:  Klin Oczna        ISSN: 0023-2157


  2 in total

1.  Visuocortical function in infants with a history of neonatal jaundice.

Authors:  Chuan Hou; Anthony M Norcia; Ashima Madan; William V Good
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-09-02       Impact factor: 4.799

2.  Prenatal exposure to legacy contaminants and visual acuity in Canadian infants: a maternal-infant research on environmental chemicals study (MIREC-ID).

Authors:  C Polevoy; T E Arbuckle; Y Oulhote; B P Lanphear; K A Cockell; G Muckle; D Saint-Amour
Journal:  Environ Health       Date:  2020-02-07       Impact factor: 5.984

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.